Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13342 berlin germany - mesterolone - tablet - each tablet proviron contains 25 mg mesterolone. - androgens: 5-androstanon-(3) derivatives

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13342 berlin germany - dienogest & ethinyl estradiol - tablet - 26 hormone-containing film-coated tablets in the… - hormonal contraceptives: fixed combinations of

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13342 berlin germany - iopromide - solution for injection/infusion - 1 ml contains 623 mg iopromide (equivalent to 300… - contrast media - non-iodinated x-ray contrast

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13353 berlin germany - iopromide - solution for injection/infusion - 1 ml contains 769 mg iopromide (equivalent to 370… - contrast media - iodinated x-raycontrast media:

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag m�_llerstr. 178 13353 berlin - dienogest - tablet - each tablet contains 2 mg dienogest - progestogens: pregnadienderivatives

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13342 berlin germany - rivaroxaban - tablet - 1 film-coated tablet contains 20 mg rivaroxaban. - antithrombotic agents: direct factor xa inhibitors

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 51368 leverkusen germany - rivaroxaban - tablet - 1 film-coated tablet contains 10 mg rivaroxaban. - antithrombotic agents: direct factor xa inhibitors

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13342 berlin germany - rivaroxaban - tablet - 1 film-coated tablet contains 15 mg rivaroxaban. - antithrombotic agents: direct factor xa inhibitors

Kenya - English - Pharmacy and Poisons Board

bayer pharma ag bayer pharma ag 13342 berlin germany - drospirenone / ethinyl estradiol - tablet - 21 hormone-containing light yellow film-coated… - hormonal contraceptives: fixed combinations of

European Union - English - EMA (European Medicines Agency)

bayer pharma ag - regorafenib - colorectal neoplasms - antineoplastic agents, protein kinase inhibitors - stivarga is indicated as monotherapy for the treatment of adult patients with:metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies - these include fluoropyrimidine-based chemotherapy, an anti-vegf therapy and an anti-egfr therapy;unresectable or metastatic gastrointestinal stromal tumors (gist) who progressed on or are intolerant to prior treatment with imatinib and sunitinib;hepatocellular carcinoma (hcc) who have been previously treated with sorafenib.